1. Home
  2. LIDRW vs OSRHW Comparison

LIDRW vs OSRHW Comparison

Compare LIDRW & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc. Warrant

LIDRW

AEye Inc. Warrant

N/A

Current Price

$0.12

Market Cap

0.0

ML Signal

N/A

Logo OSR Holdings Inc. Warrant

OSRHW

OSR Holdings Inc. Warrant

N/A

Current Price

$0.05

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LIDRW
OSRHW
Founded
N/A
N/A
Country
United States
United States
Employees
45
21
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
LIDRW
OSRHW
Price
$0.12
$0.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
LIDRW
OSRHW
Relative Strength Index (RSI) 48.25 N/A
Support Level $0.09 N/A
Resistance Level $0.17 N/A
Average True Range (ATR) 0.02 0.00
MACD 0.00 0.00
Stochastic Oscillator 28.24 0.00

Price Performance

Historical Comparison
LIDRW
OSRHW

About LIDRW AEye Inc. Warrant

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: